Related Experiment Videos
Altered glucose homeostasis in alpha2A-adrenoceptor knockout mice
Veronica Fagerholm1, Tove Grönroos, Päivi Marjamäki
1Department of Pharmacology and Clinical Pharmacology, University of Turku, Itäinen Pitkäkatu 4B, FI-20520 Turku, Finland.
European Journal of Pharmacology
|November 24, 2004
Summary
The alpha-2A adrenoceptor is key for maintaining blood glucose homeostasis. Knockout mice lacking this receptor showed altered glucose levels and no drug response, indicating its primary role.
Area of Science:
- Pharmacology
- Endocrinology
- Metabolic Regulation
Background:
- Alpha-2 adrenoceptors play a role in metabolic regulation.
- Understanding specific subtype functions is crucial for metabolic research.
Purpose of the Study:
- To determine the role of alpha-2A adrenoceptor subtypes in metabolic regulation.
- To investigate the effects of alpha-2 adrenoceptor agonists and antagonists on glucose and insulin levels.
Main Methods:
- Utilized C57Bl/6J wild-type (WT) and alpha-2A adrenoceptor knockout (alpha2A-KO) mice.
- Administered alpha-2 adrenoceptor agonist (dexmedetomidine) and antagonist (atipamezole).
- Measured plasma glucose, insulin, and tissue uptake of 2-[18F]fluoro-2-deoxy-d-glucose ([18F]FDG).
Main Results:
- Alpha2A-KO mice exhibited 30% lower basal glucose levels than WT mice.
- In WT mice, dexmedetomidine altered insulin and glucose levels, while atipamezole reduced glucose.
- Neither drug affected glucose or insulin levels in alpha2A-KO mice, with absent [18F]FDG tissue uptake changes.
Conclusions:
- The alpha-2A adrenoceptor is the primary subtype regulating in vivo blood glucose homeostasis.
- Alpha-2A adrenoceptor signaling is essential for mediating the metabolic effects of adrenoceptor drugs.